Effect of Acid Suppressants on the Risk of COVID-19: A Propensity Score-Matched Study Using UK Biobank

Gastroenterology. 2021 Jan;160(1):455-458.e5. doi: 10.1053/j.gastro.2020.09.028. Epub 2020 Sep 24.

¹ Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio; Department of Infectious Diseases, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
² Department of Infectious Diseases, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
³ Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio.
⁴ Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio; Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio; Department of Molecular Medicine, Case Western Reserve University, Cleveland, Ohio.
⁵ Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
⁶ Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio; Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio; Department of Molecular Medicine, Case Western Reserve University, Cleveland, Ohio. Electronic address: nagyL3@ccf.org.

No abstract available

Keywords: Acid Suppressants; COVID-19; Omeprazole; Susceptibility.

Publication types